The first stop for professional medicines advice

Administering

50 results

RelevanceNewest firstOldest firstTitle
Applied filters

Self-administration of medicines

25 January 2023Self-administering medicines in hospital can benefit patients and organisations alike and should be encouraged wherever it is safe to do

Medicine administration by registered and non-registered staff

24 January 2023Administration of medicines needs to be undertaken by appropriately trained healthcare staff operating under a legal governance framework

Specific advice for using medicines following bariatric surgery

31 March 2022There is some evidence on the effect of bariatric surgery (gastric bypass) on specific medicines which may inform prescribing decisions for those patients.

Considerations for using medicines following bariatric surgery

31 March 2022Guidance on the physiological changes after bariatric surgery that can affect the absorption of medicines and supplements.

How enteral feeding tubes affect medicines

8 March 2022A knowledge of the different types of enteral feeding tube is important when recommending options for medicines administration

Including medicines with Risk Minimisation Measures (RMM) in PGDs

16 March 2021This article reflects MHRA guidance on the use of PGDs for medications which have risk minimisation measures (RMM).

Supply and/or administration of Controlled Drugs under a PGD

16 November 2021This article summarises the legal position on the supply and/or administration of controlled drugs under PGDs.

Using a Patient Group Direction to adjust doses of medicines

16 November 2021This article outlines why PGDs cannot be used to adjust the dosage of a medicine already in an individual's possession

Off label medicine use under a Patient Group Direction

10 June 2021This article explains the legislation and guidance on the use of PGDs when a medicine is to be used outside its licence ('off label')

About SPS Cytotoxic Drug and Biopharmaceutical Stability monographs and advice

24 August 2020Validated stability data ensures products compounded by cytotoxic reconstitution processes within aseptic units are safe for patients